Company overview
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing KRRO with another company.
| Daily close (USD) | $10.58 |
| Market capitalization (USD) | $155,797,334.68 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.51 |
No matching rows. Clear the filter to see all records.
Read KRRO's valuation metrics
Company size
Korro Bio, Inc. Common Stock's recorded market capitalization is $155,797,334.68. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
KRRO's recorded price-to-book ratio is 1.51. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Korro Bio, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about KRRO. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow KRRO's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.